1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, S; Mitchell, VA; Safaei, R; Vaughan, CW | 1 |
| Chapman, V; Clayton, NM; Elmes, SJR; Kendall, DA; Medhurst, SJ; Wilson, AW; Winyard, LA | 1 |
2 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Inflammation
| Article | Year |
|---|---|
Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain.
Topics: Analgesics; Animals; Disease Models, Animal; Dronabinol; Excitatory Amino Acid Antagonists; Inflammation; Ligation; Male; Motor Activity; Neuralgia; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2005 |
Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.
Topics: Analgesics; Animals; Cannabinoids; Carrageenan; Dronabinol; Drug Combinations; Hyperalgesia; Inflammation; Male; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Treatment Outcome; Weight-Bearing | 2005 |